Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.
Oncology Strategy and Expands Intellectual Property Foundation for Combination Therapies Across Solid Tumors ATLANTA, GA - ...
NGGT002 (NGGT), JNT-517 (Jnana Therapeutics), Pegvaliase (BioMarin), and others under investigation, the phenylketonuria ...
Axol Bioscience has acquired the ophthalmology business of Newcells Biotech in a deal that broadens its range of induced ...
GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a ...
Segun Fatumo discusses how he is working towards a true global genomics framework and strengthening African research capacity ...
News Medical on MSN
Axol Bioscience acquires ophthalmology business from Newcells Biotech
Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and ...
Single-Use Assemblies Market OverviewThe global single-use assemblies market is projected to expand at an approximate compound annual growth rate of 16% over the coming five years, reflecting the ...
The gene therapy, which was acquired by Novartis in 2023, is also being tested in a separate Phase I/II trial of pediatric ...
AZoLifeSciences on MSN
Human 3D model shows how the gut drives neurodegeneration
Research on a 3D microfluidic model highlights gut-brain interactions, offering new insights into inflammatory processes ...
Recent research suggests that lower IQ and cognitive performance link to higher alcohol use disorder risk, but education and ...
Team USA figure skater Alysa Liu has not only captivated fans at the 2026 Olympics with her skating abilities, but also with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results